Tinphy New Materia

Tinphy New Material is a specialized biotechnology company focused on the development and manufacture of high-purity pharmaceutical excipients and advanced drug delivery materials. The company primarily specializes in lipid nanoparticle (LNP) components, including ionizable lipids, PEGylated lipids, and helper lipids such as DSPC and cholesterol, which are essential for mRNA vaccines and gene therapies. Based in Suzhou, China, Tinphy provides critical raw materials and CDMO services to global biopharmaceutical companies to support the delivery of nucleic acid-based medicines. Their portfolio includes a wide range of catalog products, including lipids used in major COVID-19 vaccines, as well as custom synthesis capabilities for novel delivery systems. The company operates state-of-the-art GMP manufacturing facilities to ensure the high quality and scalability required for clinical and commercial applications.